Sign Up Today and Learn More About Trace Genomics Stock
Invest in or calculate the value of your shares in Trace Genomics or other pre-IPO companies through EquityZen's platform.
Trace Genomics Stock (TRGE)
Advanced prevention and management of agricultural diseases.
About Trace Genomics Stock
Founded
2015
Headquarters
San Francisco, CA, US
Total Funding
22.9M
Industries
Science and Engineering, Agriculture and Farming, Biotechnology
Trace Genomics Press Mentions
Stay in the know about the latest news on Trace Genomics
Green Technology & Sustainability Market Report 2025: Global Green Tech Market to Skyrocket to $73.9 Billion by 2030, Driven by AI & ESG Compliance
globenewswire • Mar 20, 2025
Precision farming system with scaled soil characteristics
patents • Feb 08, 2025
Soil health indicators using microbial composition
patents • Feb 08, 2025
Precision farming system with sustainability measure
patents • Feb 08, 2025
Trace Genomics on LinkedIn: Trace Genomics: Next Level Soil Testing Technology to Better Understand…
linkedin • Aug 03, 2024
Trace Genomics Management
Leadership team at Trace Genomics
Data Scientist
David Stone
Operations Manager
Lisa Becker
Join now and verify your accreditation status to gain access to:
- Trace Genomics Current Valuation
- Trace Genomics Stock Price
- Trace Genomics Management
- Available deals in Trace Genomics and all other companies with relevant Deal Offering documents
- EquityZen's proprietary data and insights, which may include
- Trace Genomics Cap Table and Funding History by Share Class and Liquidity Preferences
- Trace Genomics Revenue and Financials
- Trace Genomics Highlights
- Trace Genomics Business Model
- Trace Genomics Risk Factors
- Trace Genomics Research Report from SACRA Research
Trading Trace Genomics Stock
How to invest in Trace Genomics stock?
Accredited investors can buy pre-IPO stock in companies like Trace Genomics through EquityZen funds. These investments are made available by existing Trace Genomics shareholders who sell their shares on our platform. Typically, these are early employees who need to fund a life event – house, education, etc. Accredited investors are then offered the opportunity to invest in this stock through a fund, like those used by hedge funds serving large investors. While not without risk, investing in private companies can help investors reach goals of portfolio diversification, access to potential growth and high potential return. Learn more about our Guided Investment process here.
How to sell Trace Genomics stock?
Shareholders can sell their Trace Genomics stock through EquityZen's private company marketplace. EquityZen's network includes over 360K accredited investors interested in buying private company stock. Learn more about the easy and guided Shareholder process here.
If I invest, how do I exit my investment?
There are two ways to exit your private company investment on EquityZen's marketplace. The first is if the company has an exit event like an IPO, merger or acquisition. In that case, we will distribute the shares and/or cash to you directly. The second way is through an Express Deal on EquityZen, if eligible. An Express Deal allows you to sell your allocation of private shares in a given private company to another investor on EquityZen's marketplace. More information on Express Deals can be found here and exit information can be found here.
Why choose EquityZen?
Since 2013, the EquityZen marketplace has made it easy to buy and sell shares in private companies. EquityZen brings together investors and shareholders, providing liquidity to early shareholders and private market access to accredited investors. With low investment minimums through our funds and with more than 46K private placements completed across 450+ companies, EquityZen leads the way in delivering "Private Markets for the Public."
